# A Phase Ia Clinical Trial of HW241045

> **NCT07448194** · PHASE1 · RECRUITING · sponsor: **Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.** · enrollment: 56 (estimated)

## Conditions studied

- Healthy Volunteers
- IPF

## Interventions

- **DRUG:** HW241045
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07448194
- **Lead sponsor:** Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-24
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07448194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07448194, "A Phase Ia Clinical Trial of HW241045". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07448194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*